Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    IN8bio Inc.

    NASDAQ: INAB · Real-Time Price · USD
    2.20
    -0.06 (-2.65%)
    At close: Jun 16, 2025, 3:59 PM
    2.27
    3.18%
    After-hours: Jun 16, 2025, 06:39 PM EDT

    IN8bio Statistics

    Share Statistics

    IN8bio has 3.44M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 3.44M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0.02%

    Owned by Institutions (%)

    n/a
    		 63.46%

    Shares Floating

    n/a
    		 2.7M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,893

    FTD / Avg. Volume

    n/a
    		 4.27%

    Short Selling Information

    The latest short interest is 3.02M, so 87.56% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.02M

    Short % of Shares Out

    n/a
    		 87.56%

    Short % of Float

    n/a
    		 100.77%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.45 and the forward PE ratio is -0.37. IN8bio's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.45

    Forward PE

    n/a
    		 -0.37

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.95

    P/FCF Ratio

    n/a
    		 -0.57

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for IN8bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.35.

    Current Ratio

    n/a
    		 4.08

    Quick Ratio

    n/a
    		 4.08

    Debt / Equity

    n/a
    		 0.35

    Debt / EBITDA

    n/a
    		 -0.18

    Debt / FCF

    n/a
    		 -0.21

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,690,944.44

    Employee Count

    n/a
    		 18

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -93.06% in the last 52 weeks. The beta is 0.18, so IN8bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.18

    52-Week Price Change

    n/a
    		 -93.06%

    50-Day Moving Average

    n/a
    		 4.4

    200-Day Moving Average

    n/a
    		 7.64

    Relative Strength Index (RSI)

    n/a
    		 26.6

    Average Volume (20 Days)

    n/a
    		 137,883

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -30.44M

    Net Income

    n/a
    		 -30.44M

    EBITDA

    n/a
    		 -27.78M

    EBIT

    n/a
    		 -30.44M

    Earnings Per Share (EPS)

    n/a
    		 -17.1
    Full Income Statement

    Balance Sheet

    The company has 11.12M in cash and 5.03M in debt, giving a net cash position of 6.09M.

    Cash & Cash Equivalents

    n/a
    		 11.12M

    Total Debt

    n/a
    		 5.03M

    Net Cash

    n/a
    		 6.09M

    Retained Earnings

    n/a
    		 -121.66M

    Total Assets

    n/a
    		 19.87M

    Working Capital

    n/a
    		 9.77M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -24.15M and capital expenditures -104K, giving a free cash flow of -24.25M.

    Operating Cash Flow

    n/a
    		 -24.15M

    Capital Expenditures

    n/a
    		 -104K

    Free Cash Flow

    n/a
    		 -24.25M

    FCF Per Share

    n/a
    		 -13.59
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    INAB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for INAB is $108, which is 4657.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $108

    Price Target Difference

    n/a
    		 4657.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 6, 2025. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Jun 6, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -11.71

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist